Characterisation of kinetics of biomarkers for cell ageing and resilience in geriatric tumorpatients after urooncological operations.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032874

Enrollment

Registered

2023-10-19

Start date

2022-04-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C64 C67

Interventions

Group 1: Standard of care, high-risk patient (EI=4), no intervention Estimation of ADL and colecting blood samples (biomarker) prior to operation, at discharge, after 1,3 and 6 months postoperatively.

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Planned radical Cystektomy or Kidney operation in curative intention

Exclusion criteria

Exclusion criteria: Age under 65 years, metastatic disease, neoadjuvant chemotherapy

Design outcomes

Primary

Measure	Time frame
Functional deterioration, defined as ADL-reduction. Endpoint ist estimated 1, 3 and 6 months after operation.	—

Secondary

Measure	Time frame
Overall mortality	—

Countries

Germany

Contacts

Public ContactChristian Fiebig

Urologische und Kinderurologische Klinik, Uniklinikum Erlangen

christian.fiebig@uk-erlangen.de+499131 8223178

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026